Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue

Arthritis Res. 2000;2(2):142-4. doi: 10.1186/ar78. Epub 2000 Feb 24.

Abstract

Acute-phase serum amyloid A (A-SAA) is a major component of the acute-phase response. A sustained acute-phase response in rheumatoid arthritis (RA) is associated with increased joint damage. A-SAA mRNA expression was confirmed in all samples obtained from patients with RA, but not in normal synovium. A-SAA mRNA expression was also demonstrated in cultured RA synoviocytes. A-SAA protein was identified in the supernatants of primary synoviocyte cultures, and its expression colocalized with sites of macrophage accumulation and with some vascular endothelial cells. It is concluded that A-SAA is produced by inflamed RA synovial tissue. The known association between the acute-phase response and progressive joint damage may be the direct result of synovial A-SAA-induced effects on cartilage degradation.

MeSH terms

  • Acute Disease
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / physiopathology
  • Biomarkers / analysis
  • Humans
  • RNA, Messenger / metabolism
  • Serum Amyloid A Protein / genetics*
  • Serum Amyloid A Protein / immunology
  • Serum Amyloid A Protein / metabolism
  • Synovial Membrane / immunology*
  • Synovial Membrane / metabolism*
  • Synovial Membrane / pathology

Substances

  • Biomarkers
  • RNA, Messenger
  • Serum Amyloid A Protein